INTRODUCTION
============

Polyphenols are plant secondary metabolites that are present in a diverse range of foods and beverages such as tea, coffee, wine, fruit, vegetables, whole-grain cereals, and cocoa. Their antioxidant properties have raised considerable interest and a large number of clinical, preclinical, and epidemiologic studies have suggested a possible role in the prevention of chronic diseases such as cardiovascular diseases, diabetes, cancers, osteoporosis, and neurodegenerative diseases ([@bib1]--[@bib3]). The strongest evidence of health-protective effects is for cardiovascular diseases ([@bib4]--[@bib7]). In contrast, epidemiologic evidence that polyphenol intake protects against cancer is still limited and inconsistent ([@bib8]--[@bib11]), although many experimental studies in animal and cell culture models and a few human interventions have shown that polyphenols may exert anticarcinogenic effects ([@bib12], [@bib13]). More epidemiologic studies are required to further explore associations between polyphenol intake and the risk of cancers and other diseases.

Large-scale observational epidemiologic studies investigating the relation between polyphenol intake and health rely on the accurate estimation of intake by participants, but measurement of intake is challenging because of the large number of compounds present in foods, their distribution across a wide range of foods, and the many factors that may affect their contents in foods such as plant variety, season of harvest, or food processing and cooking ([@bib14]). The most common dietary assessment methods use food-frequency questionnaires (FFQs)[^4^](#fn2){ref-type="fn"}, 24-h dietary recalls (24-HDRs), and food diaries ([@bib15]). These methods rely on both the participants' ability to report their own food intake and the availability of reliable data on the polyphenol contents of foods, which often results in biases and measurement errors. More refined techniques for dietary assessment of polyphenol intake are therefore required. The use of innovative technologies and methodologies for the dietary assessment of polyphenol intake such as the collection of multiple 24-HDRs and food records and interactive computer- and camera-based technologies may facilitate this process ([@bib16], [@bib17]). Alternatively, biomarkers that reflect the intake of individual or groups of polyphenols may be measured. Recent developments in analytic techniques and in metabolomics should allow the measurement of large sets of polyphenols in blood or urine as indicators of exposure to the polyphenol metabolome, which is defined as the whole set of polyphenols or polyphenol metabolites present in foods or in human biospecimens ([@bib18]).

The aim of this article is to review and critically evaluate the techniques available for measuring exposure to the polyphenol metabolome. The advantages and limits of methods based on dietary assessment and biomarkers are successively discussed. Results of observational epidemiologic studies on polyphenols and cancer obtained by either of the 2 approaches are compared. With \>500 polyphenols known in foods, the data described in this article also suggest some promising approaches for characterizing the complex relations between exposure to highly diverse families of bioactive constituents in foods and the associated disease risk.

THE POLYPHENOL METABOLOME
=========================

Dietary polyphenols form a large family of \>500 different molecules with highly diverse structures and are divided into 4 main classes: flavonoids, phenolic acids, lignans, and stilbenes ([@bib14]). Flavonoids are themselves distributed into several subclasses: anthocyanidins, flavonols, flavanones, flavones, flavanols or flavan-3-ols (including monomers, proanthocyanidin oligomers and polymers and the oxidized theaflavins and thearubigins), isoflavones, chalcones, dihydrochalcones, and dihydroflavonols. To add to this diversity, polyphenols in foods are not usually found in the free (aglycone) form but are usually bound to sugars, in the case of flavonoids, or esterified to polyols, in the case of phenolic acids ([@bib19]).

Food sources
------------

Polyphenols can be found in all plants and foods of plant origin ([@bib19]). Some, such as quercetin and (+)-catechin, occur in a wide range of foods, whereas others are characteristic of single foods, such as theaflavins in tea or phloretin in apples. Major differences in polyphenol profile can be found between members of the same botanical family. For example, both garlic and onions belong to *Alliaceae*, but only onions are a major dietary source of quercetin ([@bib14]). Polyphenol profiles in individual foods also vary as a result of variety, geographical area, state of maturity at harvest, and food processing and cooking. A range of samples must therefore be analyzed to obtain representative polyphenol content values. Polyphenols present in one variety of a plant food may also be absent from another because of variation of the expression of some biosynthetic enzymes. For example, red onions contain anthocyanins that give them their typical color, whereas white onions do not ([@bib14]).

Some dietary sources are particularly rich in polyphenols, such as spices, cocoa powder, berries, and nuts, whose polyphenol contents range from 200 to 15,000 mg/100 g ([@bib20]). Other foods such as tea, red wine, coffee, some fruit and vegetables, legumes, and cereals, although less rich in polyphenols, are more widely consumed and still constitute major sources ([@bib20]--[@bib22]).

Bioavailability
---------------

Polyphenols are usually absorbed in the small intestine or in the colon. They are almost totally metabolized in the gut mucosa and the liver and conjugated to glucuronide, sulfate, and/or methyl groups. Polyphenols that reach the colon are extensively transformed by the microbiota; and their main products, phenolic acids, are themselves absorbed and found in the systemic circulation. Finally, these metabolites are largely excreted in urine and the bile, usually within 24--48 h ([@bib19], [@bib23]).

The chemical structures of polyphenols greatly influence gut absorption and metabolic fate in the body. The recovery in urine of intact polyphenols can be as low as \<0.01% for anthocyanins or as high as 43% for some isoflavones ([@bib23]). Glycosylation of flavonoids and esterification of phenolic acids are key factors affecting their absorption from the gut. The type of glycosylation also influences bioavailability. Glucosides of quercetin, as found in onions, are efficiently absorbed in the small intestine, whereas rhamnoglucosides of quercetin are poorly absorbed until they reach the colon where they are deglycosylated by the microbiota and finally absorbed as quercetin aglycone ([@bib23]--[@bib25]). Esterification also limits the bioavailability of phenolic acids when compared with their free form ([@bib26], [@bib27]). These few examples show that it is essential to take into account the fine chemical structures of polyphenols to understand their role in the prevention of diseases through epidemiologic studies.

MEASURING POLYPHENOL INTAKE THROUGH DIETARY ASSESSMENT
======================================================

The most common method of estimating polyphenol intake in epidemiologic studies is to use dietary questionnaires, such as FFQs, 24-HDRs, and food diaries, to record all food consumption over a prescribed time period. Food-composition tables built from databases are then used to estimate intake per individual. The estimation of intake is complex, because many foods contribute to polyphenol intake; for example, 232 foods contributed to the intake of 337 polyphenols in the French SU.VI.MAX (Supplementation en Vitamines et Mineraux Antioxydants) cohort ([@bib21]). It is therefore important to collect accurate data on the intake of all polyphenol-containing foods together with accurate content values for all polyphenols in these foods.

Databases on polyphenol content in foods and polyphenol intake measurement
--------------------------------------------------------------------------

Food-composition tables for polyphenols are built with the use of data from large polyphenol databases containing extensive food-composition data extracted from the scientific literature ([@bib28], [@bib29]). Analytic methods used to obtain these data vary, and the quality of the analyses must be carefully evaluated before data are accepted for inclusion in these databases and exploited to build food-composition tables. HPLC is sensitive and specific and is the method most commonly used to quantify individual polyphenols. A hydrolysis step is sometimes necessary to convert glycosides to their aglycones to simplify the analysis of complex extracts when standards for individual glycosides are not available. Alternatively, total polyphenols may be measured by using the Folin-Ciocalteu colorimetric assay, which provides crude estimates of polyphenol contents in foods. However, the assay is susceptible to interference by other nonphenolic constituents that may be present such as ascorbic acid, sugars, and other reducing agents ([@bib20]) and different analytic methods should then be used. Where possible, content data for individual polyphenols should be preferred given their variable bioavailabilities and bioactivities.

The first database on polyphenol contents in foods was developed by the USDA in the early 2000s and has been periodically updated since. It provides data on the contents of 38 of the most important flavonoids in foods, expressed as aglycones ([@bib28], [@bib30], [@bib31]). In 2009, Phenol-Explorer, a comprehensive Web database on the content in foods of all known polyphenols, was released. It contains data on 502 polyphenols from all classes (flavonoids, phenolic acids, lignans, and stilbenes) and thus differs from the USDA database by its more comprehensive coverage of dietary polyphenols ([@bib29]). The content in food of all known aglycones and their glycosides or esters are described. This detailed information on all individual polyphenol compounds is important because glycosylation and esterification strongly influence gut absorption and bioavailability of polyphenols (*see* previous subsections).

The USDA and Phenol-Explorer databases have recently been exploited in France and Finland to provide the most comprehensive data on polyphenol exposure. A mean total polyphenol intake of ∼850 mg/d (polyphenols expressed as aglycone equivalents) was reported in both studies ([@bib21], [@bib22]). Phenolic acids accounted for the highest proportion of all dietary polyphenols (50--75% of total intake) followed by flavonoids (25--50%). Intake of polyphenols from other classes was very limited (\<30 mg/d). Mean flavonoid intake was also compared in different European countries and ranged from 161 to 428 mg/d (expressed as aglycone equivalents) ([@bib32]). Intake was most influenced by the consumption of coffee and tea, which were the most frequently consumed polyphenol-containing foodstuffs. Polyphenol intake was also shown to be associated with age, sex, socioeconomic status, and ethnicity, all factors known to affect food choices ([@bib32], [@bib33]).

Limitations of polyphenol intake estimations
--------------------------------------------

Despite advances in dietary data collection techniques that have decreased the frequency of systematic and random measurement errors ([@bib15], [@bib34]), dietary questionnaires are subject to bias as a result of self-reporting. Participants may report perceived acceptable rather than actual food intakes or just report foods inaccurately. Data from FFQs only concern the foods most commonly consumed by the target population and may not be detailed enough to reliably estimate the intake of highly diverse polyphenol-containing foods. More precise polyphenol intake measurements are obtained when using 24-HDRs or food diaries, but only short-term intake is measured unless repeated measurements are carried out during the year to provide more long-term intake estimates as required in epidemiologic studies ([@bib16], [@bib17]).

Databases on polyphenol content in foods also have their limitations. Polyphenol content in a given food can vary widely according to plant species, time of year, year of harvest, and extent of processing. The exact nature of the foods and beverages consumed and their mode of preparation are not always fully documented in dietary records. Red and white wines differ greatly in their polyphenol content but their intake is often not distinguished in dietary records. Polyphenol concentrations in coffee are also quite different between an espresso and a cup of filtered coffee ([@bib35]), and the brewing method used by individuals is often not available. In addition, the reliability of a particular polyphenol content value increases with the number of samples analyzed to produce a representative mean content value ([@bib29]). Polyphenol content values may be missing for some foods, and missing data cannot be easily extrapolated because polyphenol profiles may vary considerably between similar foods. For example, citrus fruit are the main sources of flavanones, but each citrus fruit provides different profiles of flavanones. Oranges are rich in hesperetin and naringenin, grapefruit in naringenin, lemons in eriodictyol and hesperetin, and limes in hesperetin ([@bib28], [@bib29]). Furthermore, polyphenol contents change with processing, such as after cooking, storing, jam-making, canning, and freezing. For example, flavonoid losses of 30--75% have been reported after different culinary treatments ([@bib36], [@bib37]). New information on polyphenol retention factors after cooking and processing has been recently incorporated into the Phenol-Explorer database ([@bib38]). This will further improve the coverage and accuracy of polyphenol food-composition data. Last, some polyphenols are commonly used as additives in food formulation ([@bib39]). They can serve as natural or synthetic phenolic pigments (eg, elderberry and grape skin extracts rich in anthocyanins) or preservatives (eg, rosemary extracts rich in phenolic acids). Their contribution to polyphenol intake is not known.

Another limitation of polyphenol intake measurements is the lack of accurate data on the consumption of polyphenols from dietary supplements. Many herbal or plant extract supplements that are rich in polyphenols have been marketed worldwide for \>20 y. They may contain much greater quantities of polyphenols than are possible to ingest naturally from foods. In general, dietary supplements have not been considered in polyphenol databases and food-composition tables, and few resources exist on the identity and composition of polyphenol supplements given the wide and unregulated product market ([@bib40]--[@bib42]). The estimation of the polyphenol content of dietary supplements is also problematic. Dietary supplements are regulated as foods (eg, by the European Food Safety Agency in Europe and the Food and Drug Administration in the United States), and polyphenol contents are often not indicated on the label. Polyphenol content in supplements varies widely, as has been shown for soy isoflavone products commonly consumed as alternatives to hormone replacement therapy, and the dose indicated on the supplement label was often found to be unreliable ([@bib43], [@bib44]). Overall, this lack of data may result in the underestimation of intake for some specific phenolic compounds or among particular populations such as those taking polyphenol-rich supplements.

MEASURING POLYPHENOL EXPOSURE THROUGH BIOMARKERS
================================================

Polyphenol biomarkers could replace or complement traditional dietary assessment as a means of reducing self-reporting inaccuracies and improve the reliability of exposure measurements ([@bib45]). Biomarkers in the field of nutrition can be defined as any compound measurable in biological specimens that is an indicator of intake, exposure, or status of some food or nutrient ([@bib46]). Being independent of the errors associated with dietary questionnaires, their use provides more objective estimates of exposure that can be used to validate measurements of dietary intake. Unfortunately, such a validation has rarely been performed for polyphenols. This may raise doubts about the reliability of some epidemiologic data on polyphenols and diseases. Biomarkers may be particularly useful when reliable food content values are missing (eg, no difference is generally made in questionnaires between different types of coffee varying widely in their dilution) or when a polyphenol compound is distributed in a large diversity of foods (eg, quercetin present in tea, onions, and various other fruit and vegetables), making the evaluation of its intake particularly difficult and prone to errors.

Most of the epidemiologic studies that have used polyphenol biomarkers concern flavonols, isoflavones, and lignans, particularly for cancer studies as presented in [**Table 1**](#tbl1){ref-type="table"}. These 3 classes of polyphenols account for only a minor fraction of all polyphenols regularly consumed (∼50 mg of a total of 1193 mg consumed per day in a French cohort) ([@bib21]). The same polyphenol biomarkers have also been measured in cross-sectional studies aiming to validate tools and methods for measurement of polyphenol intake ([**Table 2**](#tbl2){ref-type="table"}). Notably, the applicability of polyphenol biomarkers in epidemiologic studies relies on their ability to reflect the dose ingested, reliability over time, and availability of appropriate analytic methods for their estimation in biospecimens.

###### 

Epidemiologic studies on the association between polyphenol biomarkers and cancer[*^1^*](#tblfn1){ref-type="table-fn"}

  Cancer site and polyphenol class   Biomarker                                                         Specimen   Type of study   Country                   Population   Cases   Sex           Age      Follow-up   Type of variable   Association                                              [*^2^*](#tblfn2){ref-type="table-fn"}   Ref
  ---------------------------------- ----------------------------------------------------------------- ---------- --------------- ------------------------- ------------ ------- ------------- -------- ----------- ------------------ -------------------------------------------------------- --------------------------------------- ------------
                                                                                                                                                            *n*          *n*     *% females*   *y*      *y*                                                                                                                             
  Breast                                                                                                                                                                                                                                                                                                                                
   Flavanols                         EC, ECG, EGC, EGCG                                                Plasma     Nested CC       Japan                     432          144     100           40--69   10.6        Tertiles           ---                                                      NS                                      ([@bib47])
   Flavanols                         EC, EGC, metabolites                                              Urine      Nested CC       China                     1054         353     100           40--70   7           Tertiles           ---                                                      NS                                      ([@bib48])
   Flavanones                        Hesperetin and naringenin                                         Urine      CC              China                     500          250     100           25--64               Tertiles           ---                                                      NS                                      ([@bib49])
   Flavonols                         Quercetin, kaempferol                                             Urine      Nested CC       China                     1054         353     100           40--70   7           Tertiles           ---                                                      NS                                      ([@bib48])
   Isoflavonoids                     GEN                                                               Plasma     Nested CC       Japan                     432          144     100           40--69   10.6        Quartiles          0.34 (0.16, 0.74)[*^3^*](#tblfn3){ref-type="table-fn"}   0.02                                    ([@bib50])
   Isoflavonoids                     DAI                                                               Plasma     Nested CC       Japan                     432          144     100           40--69   10.6        Quartiles          ---                                                      NS                                      ([@bib50])
   Isoflavonoids                     GEN                                                               Plasma     Nested CC       Netherlands               766          383     100           35--70   6.5         Tertiles           0.68 (0.47, 0.98)                                        0.07                                    ([@bib51])
   Isoflavonoids                     Equol                                                             Urine      Nested CC       UK                        333          114     100           45--75   8           Log~2~             1.34 (1.06, 1.70)                                        0.013                                   ([@bib52])
   Isoflavonoids                     DAI                                                               Serum      Nested CC       UK                        284          97      100           45--75   8           Log~2~             1.22 (1.01, 1.48)                                        0.044                                   ([@bib52])
   Isoflavonoids                     GEN                                                               Serum      Nested CC       UK                        284          97      100           45--75   8           Log~2~             ---                                                      NS                                      ([@bib52])
   Isoflavonoids                     Equol                                                             Serum      Nested CC       UK                        284          97      100           45--75   8           Log~2~             1.46 (1.05, 2.02)                                        0.024                                   ([@bib52])
   Isoflavonoids                     GLY                                                               Urine      CC              China                     120          60      100           25--64   ---         Tertiles           0.41 (0.15, 1.11)                                        0.06                                    ([@bib53])
   Isoflavonoids                     Total isoflavones, DAI, GEN, equol, O-DMA                         Urine      CC              China                     120          60      100           25--64   ---         Tertiles           ---                                                      NS                                      ([@bib53])
   Isoflavonoids                     Total isoflavones (DAI, DH-DAI, GEN, DH-GEN, GLY, equol, O-DMA)   Urine      CC              China                     334          117     100           25--64   ---         Tertiles           0.46 (0.22, 0.95)                                        0.04                                    ([@bib54])
   Isoflavonoids and lignans         ENL and GEN                                                       Urine      Nested CC       Netherlands               356          88      100           50--64   9           Tertiles           ---                                                      NS                                      ([@bib55])
   Isoflavonoids                     Total isoflavones (DAI, DH-DAI, GEN, DH-GEN, GLY, O-DMA)          Urine      CC              China                     500          250     100           25--64   ---         Tertiles           0.62 (0.39, 0.99)                                        0.04                                    ([@bib49])
   Isoflavonoids                     Equol                                                             Urine      CC              Australia                 288          144     100           30--84   ---         Quartiles          0.27 (0.10, 0.69)                                        0.009                                   ([@bib56])
   Isoflavonoids                     Total isoflavones (DAI, GEN, GLY, equol, O-DMA)                   Urine      Nested CC       UK                        1189         237     100           45--75   9.5         Log~2~             1.08 (1.00, 1.16)                                        0.055                                   ([@bib57])
   Isoflavonoids                     Total isoflavones (DAI, GEN, GLY, equol, O-DMA)                   Serum      Nested CC       UK                        1064         213     100           45--75   9.5         Log~2~             ---                                                      NS                                      ([@bib57])
   Isoflavonoids and lignans         DAI, GLY, O-DMA, equol, END, ENL                                  Plasma     Nested CC       Netherlands               766          383     100           35--70   6.5         Tertiles           ---                                                      NS                                      ([@bib51])
   Isoflavonoids and lignans         DAI, GEN, GLY, O-DMA, END, ENL                                    Urine      Nested CC       UK                        333          114     100           45--75   8           Log~2~             ---                                                      NS                                      ([@bib52])
   Isoflavonoids and lignans         GLY, END, ENL                                                     Serum      Nested CC       UK                        284          97      100           45--75   8           Log~2~             ---                                                      NS                                      ([@bib52])
   Isoflavonoids and lignans         DAI, END, matairesinol                                            Urine      CC              Australia                 288          144     100           30--84   ---         Quartiles          ---                                                      NS                                      ([@bib56])
   Lignans                           Total lignans (END, ENL)                                          Urine      CC              China                     334          117     100           25--64   ---         Tertiles           ---                                                      NS                                      ([@bib56])
   Lignans                           Total lignans (END, ENL)                                          Urine      CC              China                     500          250     100           25--64   ---         Tertiles           0.40 (0.24, 0.64)                                        \<0.001                                 ([@bib49])
   Lignans                           Total lignans (END, ENL)                                          Urine      Nested CC       UK                        1189         237     100           45--75   9.5         Log~2~                                                                      NS                                      ([@bib57])
   Lignans                           Total lignans (END, ENL)                                          Serum      Nested CC       UK                        1064         213     100           45--75   9.5         Log~2~             ---                                                      NS                                      ([@bib57])
   Lignans                           ENL                                                               Plasma     Nested CC       Sweden                    740          248     100           25--64   10          Quintiles                                                                   NS                                      ([@bib58])
   Lignans                           ENL                                                               Plasma     CC              Finland                   402          194     100           25--75   ---         Quintiles          0.38 (0.18, 0.77)                                        0.03                                    ([@bib59])
   Lignans                           ENL                                                               Urine      CC              Australia                 288          144     100           30--84   ---         Quartiles          0.36 (0.15, 0.86)                                        0.013                                   ([@bib56])
  Breast (cont\'d)                                                                                                                                                                                                                                                                                                                      
   Polyphenols (total)               Phenols                                                           Urine      CC              China                     120          60      100           25--64   ---         Tertiles           ---                                                      NS                                      ([@bib52])
  Prostate                                                                                                                                                                                                                                                                                                                              
   Isoflavonoids                     GEN, DAI, equol                                                   Serum      Nested CC       Japan                     191          40      0             \>40     9           Tertiles           ---                                                      NS                                      \(60\)
   Isoflavonoids                     DAI                                                               Urine      Nested CC       USA                       653          249     0             45--75   1.9         Quintiles          0.55 (0.31, 0.98)                                        0.03                                    ([@bib61])
   Isoflavonoids                     GEN, equol                                                        Urine      Nested CC       USA                       653          249     0             45--75   1.9         Quintiles                                                                   NS                                      ([@bib61])
   Isoflavonoids                     GEN                                                               Plasma     Nested CC       Europe                    1992         950     0             43--76   4.2         Quintiles          0.74 (0.54, 1.00)                                        0.05                                    ([@bib62])
   Isoflavonoids                     DAI, equol                                                        Plasma     Nested CC       Europe                    1992         950     0             43--76   4.2         Quintiles          ---                                                      NS                                      ([@bib62])
   Isoflavonoids                     Total isoflavones, DAI, GEN, equol                                Plasma     CC              Scotland                  454          249     0             50--74   ---         Quartiles          ---                                                      NS                                      ([@bib63])
   Isoflavonoids                     DAI, GEN, GLY, equol                                              Plasma     Nested CC       Japan                     603          201     0             40--69   12.8        Tertiles           ---                                                      NS                                      ([@bib64])
   Isoflavonoids and lignans         DAI, GEN, GLY, equol, O-DMA, END, ENL                             Plasma     Nested CC       UK                        1006         191     0             45--75   9           Log~2~             ---                                                      NS                                      ([@bib65])
   Isoflavonoids and lignans         DAI, GEN, GLY, equol, O-DMA, END, ENL                             Urine      Nested CC       UK                        817          152     0             45--75   9           Log~2~             ---                                                      NS                                      ([@bib65])
   Lignans                           ENL                                                               Urine      Nested CC       USA                       653          249     0             45--75   1.9         Quintiles          ---                                                      NS                                      ([@bib61])
   Lignans                           END, ENL                                                          Plasma     Nested CC       Europe                    1992         950     0             43--76   4.2         Quintiles          ---                                                      NS                                      ([@bib62])
   Lignans                           ENL                                                               Plasma     CC              Scotland                  454          249     0             50--74   ---         Quartiles          0.40 (0.22, 0.71)                                        0.002                                   ([@bib63])
   Lignans                           ENL                                                               Plasma     Nested CC       Finland, Sweden, Norway   3344         794     0             25--64   14.2        Quartiles          ---                                                      NS                                      ([@bib66])
  Uterine fibroids                                                                                                                                                                                                                                                                                                                      
   Isoflavonoids                     Total isoflavones (DAI, GEN, equol, O-DMA)                        Urine      CC              USA                       340          168     100           20--75   ---         Quartiles          ---                                                      NS                                      ([@bib67])
   Lignans                           Total lignans (END, ENL)                                          Urine      CC              USA                       343          170     100           20--75   ---         Quartiles          0.47 (0.23, 0.98)                                        0.07                                    ([@bib67])
  Endometrium                                                                                                                                                                                                                                                                                                                           
   Alkylresorcinols                  Alkylresorcinols (17:0, 19:0, 21:0, 23:0, 25:0)                   Plasma     Case-cohort     Denmark                   329          177     100           50--64   11          Quartiles          ---                                                      NS                                      ([@bib68])
  Esophagus                                                                                                                                                                                                                                                                                                                             
   Flavanols                         EGC + 4´-MeEGC + EC + metabolites                                 Urine      Nested CC       China                     251          42      0             45--64   12          Quartiles          ---                                                      NS                                      ([@bib69])
  Stomach                                                                                                                                                                                                                                                                                                                               
   Flavanols                         EC                                                                Plasma     Nested CC       Japan                     662          331     0             40--69   14          Tertiles           2.06 (1.23, 3.45)                                        0.003                                   ([@bib70])
   Flavanols                         ECG                                                               Plasma     Nested CC       Japan                     326          163     100           40--69   14          Tertiles           0.25 (0.08, 0.73)                                        0.02                                    ([@bib70])
   Flavanols                         ECG                                                               Plasma     Nested CC       Japan                     662          331     0             40--69   14          Tertiles           ---                                                      NS                                      ([@bib70])
   Flavanols                         EC                                                                Plasma     Nested CC       Japan                     326          163     100           40--69   14          Tertiles           ---                                                      NS                                      ([@bib70])
   Flavanols                         ECG, EGC                                                          Plasma     Nested CC       Japan                     988          494     33            40--69   14          Tertiles           ---                                                      NS                                      ([@bib70])
   Flavanols                         EGC + 4´-MeEGC + EC + metabolites                                 Urine      Nested CC       China                     753          190     0             45--64   12          Quartiles          ---                                                      NS                                      ([@bib70])
  Colorectum                                                                                                                                                                                                                                                                                                                            
   Isoflavonoids and lignans         DAI, GEN, GLY, equol, O-DMA, END, ENL                             Plasma     Nested CC       UK                        1091         214     43            45--75   9           Log~2~             ---                                                      NS                                      ([@bib65])
   Isoflavonoids and lignans         DAI, GEN, GLY, equol, O-DMA, END, ENL                             Urine      Nested CC       UK                        832          146     43            45--75   9           Log~2~             ---                                                      NS                                      ([@bib65])
  Colon                                                                                                                                                                                                                                                                                                                                 
   Flavanols                         EGC + 4´-MeEGC                                                    Urine      Nested CC       China                     498          83      0             45--64   16          Quartiles          0.42 (0.68, 0.94)                                        0.007                                   ([@bib71])
   Flavanols                         EC + metabolites                                                  Urine      Nested CC       China                     498          83      0             45--64   16          Quartiles          ---                                                      NS                                      ([@bib71])
  Rectum                                                                                                                                                                                                                                                                                                                                
   Flavanols                         EGC + 4´-MeEGC + EC + metabolites                                 Urine      Nested CC       China                     474          79      0             45--64   16          Quartiles          ---                                                      NS                                      ([@bib71])
  Lung                                                                                                                                                                                                                                                                                                                                  
   Isoflavonoids                     GEN                                                               Plasma     Nested CC       Japan                     318          106     100           40--69   13.5        Quintiles          0.31 (0.12, 0.86)                                        0.085                                   ([@bib72])
   Isoflavonoids                     Total isoflavones, DAI, GLY, equol                                Plasma     Nested CC       Japan                     318          106     100           40--69   13.5        Quintiles          ---                                                      NS                                      ([@bib72])

CC, case-control; DAI, daidzein; DH-DAI, dihydrodaidzein; DH-GEN, dihydrogenistein; EC, epicatechin; ECG, epicatechin gallate; EGC, epigallocatechin; EGCG, epigallocatechin gallate; END, enterodiol; ENL, enterolactone; GEN, genistein; GLY, glycitein; MeEGC, methylepigallocatechin gallate; O-DMA, *O*-desmethylangolensin; Ref, reference; ---, no significant association.

*P* is -trend when the association was measured in quantiles and value when association was measured continuously.

OR; 95% CI in parentheses (all such values).

###### 

Validation studies for polyphenol intake measurement showing correlations between polyphenol concentrations in plasma or urine with habitual polyphenol intake in various populations[*^1^*](#tblfn4){ref-type="table-fn"}

  Polyphenol ingested                                          Biomarker[*^2^*](#tblfn5){ref-type="table-fn"}        Biofluid       No. of subjects   Country       Dietary assessment   *r*          *P*       Ref
  ------------------------------------------------------------ ----------------------------------------------------- -------------- ----------------- ------------- -------------------- ------------ --------- ------------
  Flavonols                                                                                                                                                                                                     
   Kaempferol                                                  Kaempferol                                            Plasma (F)     48                Germany       7-d DR               0.46         \<0.01    ([@bib73])
   Quercetin                                                   Quercetin                                             Plasma (F)     48                Germany       7-d DR               0.3          \<0.05    ([@bib73])
   Kaempferol                                                  Kaempferol                                            Plasma (F)     92                China         FFQ                  0.52         0.001     ([@bib74])
   Quercetin                                                   Quercetin                                             Plasma (F)     92                China         FFQ                  0.46         0.001     ([@bib74])
   Isorhamnetin                                                Isorhamnetin                                          Plasma (F)     92                China         FFQ                  0.37         0.026     ([@bib74])
   Quercetin                                                   Quercetin                                             Plasma (F)     92                China         7-d DR               0.51         \<0.05    ([@bib75])
   Quercetin, kaempferol, isorhamnetin                         Quercetin, kaempferol, isorhamnetin                   Plasma (F)     92                China         7-d DR               0.48         \<0.05    ([@bib75])
   Kaempferol                                                  Kaempferol                                            Plasma (F)     92                China         7-d DR               0.44         \<0.05    ([@bib75])
   Isorhamnetin                                                Isorhamnetin                                          Plasma (F)     92                China         7-d DR               0.33         \<0.05    ([@bib75])
  Flavones                                                                                                                                                                                                      
   Apigenin                                                    Apigenin                                              Plasma (F)     92                China         FFQ                  0.52         0.002     ([@bib74])
   Luteolin                                                    Luteolin                                              Plasma (F)     92                China         FFQ                  0.5          0.012     ([@bib74])
   Apigenin, luteolin                                          Apigenin, luteolin                                    Plasma (F)     92                China         7-d DR               0.46         \<0.05    ([@bib75])
   Luteolin                                                    Luteolin                                              Plasma (F)     92                China         7-d DR               0.44         \<0.05    ([@bib75])
   Apigenin                                                    Apigenin                                              Plasma (F)     92                China         7-d DR               0.42         \<0.05    ([@bib75])
  Flavanones                                                                                                                                                                                                    
   Naringenin                                                  Naringenin                                            Plasma (F)     48                Germany       7-d DR               0.35         \<0.05    ([@bib73])
   Hesperetin                                                  Hesperetin                                            Plasma (F)     48                Germany       7-d DR               0.32         \<0.05    ([@bib73])
  Isoflavones                                                                                                                                                                                                   
   Daidzein                                                    Daidzein, equol, O-DMA, dihydrodaidzein               Urine (spot)   24                Korea         3 × 3-d DR           0.72         \<0.001   ([@bib76])
   Genistein                                                   Genistein, dihydrogenistein                           Urine (spot)   24                Korea         3 × 3-d DR           0.64         \<0.01    ([@bib76])
   Glycitein                                                   Glycitein                                             Urine (spot)   24                Korea         3 × 3-d DR           0.57         \<0.01    ([@bib76])
   Genistein                                                   Genistein                                             Urine (24-h)   27                USA           FFQ                  0.54                   ([@bib77])
   Daidzein                                                    Daidzein, equol, O-DMA                                Urine (24-h)   27                USA           FFQ                  0.49                   ([@bib77])
   Genistein                                                   Genistein                                             Plasma (NF)    80                UK            7-d DR               0.8          \<0.001   ([@bib78])
   Daidzein                                                    Daidzein                                              Plasma (NF)    80                UK            7-d DR               0.79         \<0.001   ([@bib78])
   Daidzein, genistein, glycitein, formononetin, biochanin A   Daidzein, genistein, equol, O-DMA                     Urine (spot)   2908              USA           24-h DR              0.48         \<0.001   ([@bib79])
   Daidzein                                                    Daidzein, equol, O-DMA                                Urine (spot)   2908              USA           24-h DR              0.46         \<0.001   ([@bib79])
   Genistein                                                   Genistein                                             Urine (spot)   2908              USA           24-h DR              0.45         \<0.001   ([@bib79])
   Genistein                                                   Genistein                                             Urine (24-h)   105               USA           FFQ                  0.31         \<0.01    ([@bib80])
   Daidzein, genistein                                         Daidzein, genistein, equol, O-DMA                     Urine (24-h)   105               USA           FFQ                  0.29         \<0.01    ([@bib80])
   Daidzein                                                    Daidzein, equol, O-DMA                                Urine (24-h)   105               USA           FFQ                  0.28         \<0.01    ([@bib80])
   Daidzein                                                    Daidzein                                              Urine (24-h)   93                Japan         14 × 24-h DR         0.43                   ([@bib81])
   Genistein                                                   Genistein                                             Plasma (F)     196               Japan         14 × 24-h DR         0.42                   ([@bib81])
   Daidzein                                                    Daidzein                                              Plasma (F)     196               Japan         14 × 24-h DR         0.39                   ([@bib81])
   Genistein                                                   Genistein                                             Urine (24-h)   93                Japan         14 × 24-h DR         0.38                   ([@bib81])
   Daidzein                                                    Daidzein                                              Urine (24-h)   69                USA           FFQ                  0.49         \<0.001   ([@bib82])
   Genistein                                                   Genistein                                             Urine (24-h)   69                USA           FFQ                  0.3          0.035     ([@bib82])
   Daidzein                                                    Daidzein, equol, O-DMA, dihydrodaidzein               Urine (24-h)   195               USA           FFQ                  0.55                   ([@bib83])
   Genistein, daidzein, biochanin A, formononetin              Genistein, daidzein, equol, O-DMA, dihydrodaidzein    Urine (24-h)   195               USA           FFQ                  0.5                    ([@bib83])
   Genistein                                                   Genistein                                             Urine (24-h)   195               USA           FFQ                  0.45                   ([@bib83])
   Daidzein, genistein                                         Daidzein, genistein, equol                            Plasma (NF)    203               Scotland      FFQ                  0.27         \<0.001   ([@bib84])
   Genistein                                                   Genistein                                             Plasma (NF)    203               Scotland      FFQ                  0.26         \<0.001   ([@bib84])
   Daidzein                                                    Daidzein, equol                                       Plasma (NF)    203               Scotland      FFQ                  0.24         0.001     ([@bib84])
   Genistein                                                   Genistein                                             Plasma (F)     96                USA           FFQ                  0.38         \<0.001   ([@bib85])
   Daidzein                                                    Daidzein                                              Plasma (F)     96                USA           FFQ                  0.35         \<0.001   ([@bib85])
   Genistein                                                   Genistein                                             Plasma (F)     77                USA           FFQ                  0.46                   ([@bib86])
   Daidzein                                                    Daidzein                                              Plasma (F)     77                USA           FFQ                  0.45                   ([@bib86])
   Daidzein, genistein, glycitein                              Daidzein, genistein, glycitein, equol, O-DMA          Urine (spot)   60                China         FFQ                  0.54         \<0.001   ([@bib87])
  Lignans                                                                                                                                                                                                       
   LARI, PINO, SECO, MAT                                       Enterolactone                                         Plasma (NF)    637               Netherlands   FFQ                  0.18         \<0.001   ([@bib88])
   LARI, PINO, SECO, MAT                                       Enterodiol                                            Plasma (NF)    637               Netherlands   FFQ                  0.09         \<0.05    ([@bib88])
   SECO, MAT                                                   Enterodiol, enterolactone                             Urine (24-h)   195               USA           FFQ                  0.16                   ([@bib83])
  Stilbenes                                                                                                                                                                                                     
   Resveratrol + piceid                                        Resveratrol metabolites (glucuronides and sulfates)   Urine (spot)   1000              Spain         FFQ                  0.89         \<0.001   ([@bib89])
  Alkylresorcinols                                                                                                                                                                                              
   Total alkylresorcinols                                      Total alkylresorcinols                                Plasma (F)     30                Sweden        3-d DR               0.33--0.40   \<0.001   ([@bib90])
   Alkylresorcinols (17:0--25:0)                               Alkylresorcinols (17:0--25:0)                         Plasma (F)     51                Sweden        2 × 3-d weighed DR   0.48--0.65   \<0.001   ([@bib91])
  Total polyphenols                                            Total polyphenols                                     Urine (spot)   60                Spain         FFQ                  0.257        0.04      ([@bib92])
                                                               Total polyphenols                                     Urine (spot)   612               Spain         FFQ                  0.179        \<0.001   ([@bib93])
                                                               Total polyphenols                                     Urine (24-h)   928               Italy         FFQ                  0.211        \<0.001   ([@bib94])

DR, dietary recall; F, fasting; FFQ, food-frequency questionnaire; LARI, lariciresinol; MAT, matairesinol; NF, nonfasting; O-DMA, *O*-desmethylangolensin; PINO, pinoresinol; Ref, reference; SECO, secoisolariciresinol.

Biomarkers were measured after deconjugation of glucuronides and sulfate esters with glucuronidases and sulfatases, respectively.

Analytic techniques for biomarker measurement
---------------------------------------------

Polyphenols are commonly measured in human biofluids after enzymatic deconjugation with glucuronidases and sulfatase, and the released aglycones are analyzed by chromatography with mass, fluorescent, or electrochemical detection ([@bib95]). Polyphenols are found in low concentrations (from nmol to μmol/L ranges) in both plasma and urine ([@bib23]), and analytic methods must be sensitive enough to allow reliable and reproducible quantitation. In a European cohort study, plasma concentrations of the ubiquitous enterolactone were below the limit of detection (LOD; 0.4 nmol/L) in 31% of subjects ([@bib96]). Similarly, in a Chinese study, plasma concentrations of quercetin, kaempferol, isorhamnetin, apigenin, and luteolin were below the LOD for 20%, 39%, 22%, 27%, and 35% of subjects, respectively ([@bib75]). There is thus a need to improve the sensitivity of analytic methods for polyphenols found in low concentrations in plasma.

LODs depend on analytic techniques and on the nature of the polyphenol biomarker. LODs commonly reported for isoflavones and lignans in plasma or urine were 10, 0.4, and 0.3 nmol/L when using HPLC coupled to diode array detection, gas chromatography--mass spectrometry, and liquid chromatography--tandem mass spectrometry techniques, respectively ([@bib84], [@bib88], [@bib96], [@bib97], [@bib98]). LODs were reported to be similar for other polyphenols: for example, 0.3 nmol/L for resveratrol in urine with the use of liquid chromatography--tandem mass spectrometry ([@bib99]) or 2.3 nmol/L for some flavonoids in plasma with the use of HPLC coupled to diode array detection ([@bib75]). Mass spectrometry techniques are evolving rapidly and should constitute the best option for the analysis of a large number of polyphenol biomarkers in a single analytic run with high sensitivity. Labeled internal standards should be used to reduce technical variability ([@bib100]--[@bib102]). However, none of the methods presented in [Table 2](#tbl2){ref-type="table"}, often based on mass spectrometry, used such labeled standards because of the high cost to synthesize them. There is a need to make these standards available at lower prices for use in large epidemiologic studies.

Polyphenol metabolism and selection of polyphenol biomarkers
------------------------------------------------------------

Choosing an appropriate polyphenol biomarker requires a good understanding of metabolism. In particular, it is essential to clearly identify all possible precursors of each biomarker, particularly for metabolites that may have several precursors. Our knowledge of polyphenol metabolism has increased enormously over the past 20 y ([@bib19], [@bib103]). More than 350 polyphenol metabolites have been described and compiled in the Phenol-Explorer database, and it is now possible to quickly identify all known precursors of a particular metabolite or all metabolites formed from a parent polyphenol ([@bib104], [@bib105]). The parent compounds, as present in the diet (generally measured in biofluids after enzymatic deconjugation of their glucuronides and sulfate esters), are the most direct indicators of exposure to the polyphenol ingested.

Polyphenol metabolites can also be measured in biofluids and have sometimes been used as biomarkers of exposure ([@bib106], [@bib107]). However, interindividual variability in their bioavailability may limit their reliability as biomarkers. Genetic factors such as polymorphisms of the xenobiotic-metabolizing enzymes may contribute to this interindividual variation ([@bib108]). The gut microbiome also differs between individuals, and this may also result in interindividual variations in the concentrations of polyphenol microbial metabolites. For example, the microbial metabolites equol, *O*-desmethylangolensin, dihydrodaidzein formed from daidzein, and dihydrogenistein from genistein were less strongly correlated with polyphenol intake than their parent compounds ([@bib109]). Therefore, they will be poorer indicators of exposure to their parent compounds.

Correlation of polyphenol biomarkers with polyphenol intake
-----------------------------------------------------------

Some polyphenol biomarkers reflect very specifically the intake of plant foods, such as resveratrol for intake of wine ([@bib89]) and alkylresorcinol metabolites for intake of whole-grain cereals ([@bib110]). A number of cross-sectional studies have shown that concentrations of these biomarkers in plasma or urine often correlate well with intakes of polyphenol-rich foods or of individual polyphenols consumed the previous day ([@bib111]). A linear response to the dose ingested has generally been observed in a large number of small acute-intervention studies, with high correlation coefficients (0.7--0.9) ([@bib109]). The strong correlations seen in intervention studies when compared with observational studies are mainly explained by a controlled or more accurate measurement of polyphenol intake, the more homogeneous population, the collection of the biospecimens straight after polyphenol intake, and the better handling and shorter storage time of biospecimens.

Polyphenol biomarkers have been measured both in urine (spot and 24-h) and plasma (fasting and nonfasting). Polyphenols are absorbed and excreted relatively quickly after ingestion, reaching maximum concentrations in plasma after as little as 0.5 h (flavanols) and as long as 9 h (isoflavones, flavonols) depending on the nature of the compounds and the food source ([@bib23]). Their elimination half-lives also vary from 1 h (flavanols) to 28 h (flavonols) ([@bib23]). These variations in concentrations in plasma resulting from rapid absorption and elimination might be less prominent in urine, because urine samples integrate polyphenol elimination over a few hours. However, in a Japanese study, both plasma and 24-h urine isoflavone concentrations correlated similarly with intake ([@bib81]), which may be explained by the relatively long half-life of isoflavones and the frequency of consumption of their food sources. Overall, no clear difference in the correlations with intake can be observed between urine and plasma for the different biomarkers ([Table 2](#tbl2){ref-type="table"}).

For isoflavones, the strongest correlations between intake and biomarker concentrations (0.57--0.72) were observed in Korean and Chinese populations in whom the consumption of soy products, rich in isoflavones, is substantially higher (32--46 mg/d) ([@bib112]) than that of Western populations. In the Western populations studied, the consumption of soy products is much less frequent and the average consumption of isoflavones did not usually exceed 2 mg/d ([@bib113]). Correlations between intake and biomarker concentrations were lower and varied between 0.24 and 0.54, with the exception of one study conducted in the United Kingdom for which high (mean isoflavone intake: 49 mg/d) and low soy consumers were selected ([@bib78]).

Plasma and urine concentrations of the 2 mammalian lignans, enterolactone and enterodiol, which are formed in the gut by the microbiota, did not reflect lignan intake (*r* = 0.10--0.20) ([@bib83], [@bib88]). This is attributed to the limited understanding of their dietary origin. In these studies, the intakes of 2 to 4 dietary lignans were measured. These lignans are present in trace amounts in a range of foods and their concentrations may be insufficient to explain the high concentrations of mammalian lignans in biofluids; other precursors, such as lignin polymers which are most abundant in whole-grain cereal products, may actually be the main precursors of the mammalian lignans ([@bib114]).

Biomarkers of flavonol and flavone consumption have been measured in plasma. Correlation with intake varied from 0.30 to 0.52 ([Table 2](#tbl2){ref-type="table"}). Similarly, correlations between alkylresorcinol concentrations in plasma and alkylresorcinol intake varied between 0.33 and 0.65 depending on the study and the nature of the polyphenol within each class. The correlation coefficient between resveratrol metabolites in spot urine and resveratrol intake was particularly high (*r* = 0.89) ([@bib89]). This finding could be attributable to the limited dietary distribution of resveratrol, whose principal contributor was wine (98%) in Spanish populations ([@bib115]).

Last, total polyphenols measured with the Folin-Ciocalteu colorimetric assay in urine were poorly correlated with total polyphenol intake measured by the same assay (*r* = 0.18--0.26). These low values are explained by the lack of specificity of the colorimetric assay used for these measurements and the well-known occurrence of interfering substances in both foods and urine, such as ascorbic acid, sugars, thiols, and other reducing agents ([@bib92]).

Biomarker reliability
---------------------

Biomarker reliability over time is another key issue to consider in epidemiology. In most prospective cohort studies, biospecimens are collected at a single time point. It is therefore essential to check that measurements made at this time point reflect usual exposure. Reliable biomarkers should be subject to little intraindividual variability relative to interindividual variability. Reliability is often expressed as the intraclass correlation (ICC) coefficient, defined as interindividual variance over total variance (intra- plus interindividual variance). Ideally, this ICC value should be close to 1. However, it rarely reaches this value because of host factors, such as variations in intestinal transit time, microbiota, and expression of metabolic enzymes and transporters that may influence polyphenol absorption and metabolism; interactions of polyphenols with other dietary factors in the gut; or the irregular consumption of the individual\'s dietary sources.

ICC values are usually measured on repeated biospecimens collected at different time intervals in a set of individuals. They have rarely been estimated for polyphenol biomarkers ([**Table 3**](#tbl3){ref-type="table"}). Low ICC values were observed for isoflavones (\<0.1) in an American cohort because of the low frequency of their consumption ([@bib118]). ICC values of ∼0.6 were measured for other flavonoids, phenolic acids, and lignans. Values were similar for biospecimens collected 4 d or 4 wk apart. In one study in which alkylresorcinols were measured in fasting and nonfasting plasma samples, the ICC coefficient was found to be lower for nonfasting plasma ([@bib91]). This is likely explained by the high intraindividual variability resulting from the different time intervals that elapsed between consumption of the sources of polyphenols during the meal and biospecimen collection. Similarly, a relatively low ICC value was observed for enterolactone when measured in nonfasting plasma samples ([@bib118]). ICC coefficients measured in these few studies suggest that plasma or urine samples can equally be used to measure polyphenol biomarkers in epidemiologic studies and fasting samples should also be recommended when available.

###### 

Summary of reliability studies on biomarkers of polyphenol consumption[*^1^*](#tblfn6){ref-type="table-fn"}

  Biomarker[*^2^*](#tblfn7){ref-type="table-fn"}   Biofluid              No. of subjects   Country   Period of sample collection   No. of samples   ICC coefficient[*^3^*](#tblfn8){ref-type="table-fn"}   Ref
  ------------------------------------------------ --------------------- ----------------- --------- ----------------------------- ---------------- ------------------------------------------------------ -------------
  Flavanols                                                                                                                                                                                                
   Gallocatechin                                   Plasma (fasting)      7                 Germany   4 wk                          3                0.60                                                   ([@bib116])
   Quercetin                                       Plasma (fasting)      7                 Germany   4 wk                          3                0.79                                                   ([@bib116])
   Quercetin                                       Urine (24-h)          154               France    4 d                           3--4             0.61                                                   ([@bib117])
   Kaempferol                                      Plasma (fasting)      7                 Germany   4 wk                          3                0.78                                                   ([@bib116])
   Kaempferol                                      Urine (24-h)          154               France    4 d                           3--4             0.54                                                   ([@bib117])
   Isorhamnetin                                    Plasma (fasting)      7                 Germany   4 wk                          3                0.68                                                   ([@bib116])
   Isorhamnetin                                    Urine (24-h)          154               France    4 d                           3--4             0.59                                                   ([@bib117])
  Flavones                                                                                                                                                                                                 
   Luteolin                                        Plasma (fasting)      7                 Germany   4 wk                          3                0.67                                                   ([@bib116])
  Flavanones                                                                                                                                                                                               
   Hesperetin                                      Plasma (fasting)      7                 Germany   4 wk                          3                0.65                                                   ([@bib116])
   Hesperetin                                      Urine (24-h)          154               France    4 d                           3--4             0.57                                                   ([@bib117])
   Naringenin                                      Urine (24-h)          154               France    4 d                           3--4             0.58                                                   ([@bib117])
  Isoflavones                                                                                                                                                                                              
   Daidzein                                        Plasma (nonfasting)   40                USA       2--3 y                        2                0.00                                                   ([@bib118])
   Daidzein                                        Urine (24-h)          45                USA       2--3 y                        2                0.00                                                   ([@bib118])
   Genistein                                       Plasma (nonfasting)   40                USA       2--3 y                        2                0.03                                                   ([@bib118])
   Genistein                                       Urine (24-h)          45                USA       2--3 y                        2                0.02                                                   ([@bib118])
   Equol                                           Plasma (nonfasting)   40                USA       2--3 y                        2                0.00                                                   ([@bib118])
   Equol                                           Urine (24-h)          45                USA       2--3 y                        2                0.09                                                   ([@bib118])
  Lignans                                                                                                                                                                                                  
   Enterolactone                                   Plasma (nonfasting)   40                USA       2--3 y                        2                0.44                                                   ([@bib118])
   Enterolactone                                   Urine (24-h)          45                USA       2--3 y                        2                0.52                                                   ([@bib118])
   Enterolactone                                   Plasma (fasting)      7                 Germany   4 wk                          3                0.70                                                   ([@bib116])
   Enterolactone                                   Urine (24-h)          154               France    4 d                           3--4             0.65                                                   ([@bib117])
   Enterodiol                                      Urine (24-h)          154               France    4 d                           3--4             0.57                                                   ([@bib117])
  Alkylresorcinols                                                                                                                                                                                         
   Total alkylresorcinols                          Plasma (fasting)      18                Sweden    3 d                           3                0.60                                                   ([@bib91])
   Total alkylresorcinols                          Plasma (nonfasting)   18                Sweden    3 d                           3                0.18                                                   ([@bib91])
  Phenolic acids                                                                                                                                                                                           
   Caffeic acid                                    Plasma (fasting)      7                 Germany   4 wk                          3                0.61                                                   ([@bib116])
   Caffeic acid                                    Urine (24-h)          154               France    4 d                           3--4             0.58                                                   ([@bib117])
   Chlorogenic acid                                Urine (24-h)          154               France    4 d                           3--4             0.64                                                   ([@bib117])
   Ferulic acid                                    Plasma (fasting)      7                 Germany   4 wk                          3                0.76                                                   ([@bib116])
   p-Coumaric acid                                 Plasma (fasting)      7                 Germany   4 wk                          3                0.67                                                   ([@bib116])
   m-Coumaric acid                                 Urine (24-h)          154               France    4 d                           3--4             0.54                                                   ([@bib117])
   Gallic acid                                     Urine (24-h)          154               France    4 d                           3--4             0.59                                                   ([@bib117])
   4-*O*-Methylgallic acid                         Urine (24-h)          154               France    4 d                           3--4             0.48                                                   ([@bib117])
   Ellagic acid                                    Plasma (fasting)      7                 Germany   4 wk                          3                0.73                                                   ([@bib116])
  Dihydrochalcones                                                                                                                                                                                         
   Phloretin                                       Urine (24-h)          154               France    4 d                           3--4             0.48                                                   ([@bib117])

ICC, intraclass correlation; Ref, reference.

Biomarkers were measured after deconjugation of glucuronides and sulfate esters with glucuronidases and sulfatases, respectively.

ICC coefficients describe the reliability of biomarkers and are defined as the proportion of variance between and within individuals.

Limitations of polyphenol biomarker measurements
------------------------------------------------

The data discussed above show the potential benefits of using biomarkers to improve the assessment of polyphenol exposures. However, polyphenol biomarkers also have a number of limitations that need to be addressed. The first is the lack of available methods combining high sensitivity and coverage to quantify the many polyphenols present in human biospecimens. Tagging polyphenols with an isotope-labeled reagent and quantification of the labeled polyphenols by mass spectrometry constitute a promising approach to both increase the sensitivity of detection and to alleviate the need for synthesizing costly labeled polyphenol standards ([@bib119], [@bib120]).

The rapid absorption and elimination of polyphenols may also limit the use of polyphenol biomarkers in observational epidemiology. Polyphenols differ from other nutritional biomarkers such as carotenoids or lipids that are partly stored in fatty tissues and which show for this reason more stable concentrations in blood ([@bib121]). However, a number of polyphenol biomarkers show ICC values that range between 0.50 and 0.79 ([Table 3](#tbl3){ref-type="table"}), which were considered "good" to "excellent" in a previous study on 86 biomarkers measured in samples from the Nurses' Health Study and comparable to ICC values of other nutritional biomarkers commonly measured in epidemiology ([@bib118]). In agreement with these relatively high ICC values, polyphenol biomarkers were not only correlated with acute polyphenol intake but also with habitual polyphenol intake as estimated with FFQs ([Table 2](#tbl2){ref-type="table"}). Nevertheless, the reliability of polyphenol biomarkers also depends on the nature of the polyphenol and on the population in whom it is applied. Isoflavone biomarkers can be used reliably in Asian populations who regularly consume soy products, whereas they are too unstable (ICC \<0.1; [Table 3](#tbl3){ref-type="table"}) in Western populations.

The availability of biological samples is another factor to consider. Polyphenol biomarkers have been measured in both plasma and urine. Urine samples are collected less often in large cohort studies, but they offer some advantages, notably higher polyphenol concentrations when compared with plasma and a more straightforward sample processing before analysis. Unlike blood, urine must be normalized to urine volume or creatinine to take into account variations in dilution ([@bib122]). The measurement of polyphenol biomarkers also requires appropriate equipment, analytic skills, and resources. Projects based on the use of polyphenol biomarkers are necessarily resource-dependent, which limits the number of samples that can be analyzed in a particular study. For these reasons, the use of polyphenol biomarkers so far has been limited to (nested) case-control studies with a number of subjects not exceeding 2000 ([Table 1](#tbl1){ref-type="table"}).

Last, when correlating many polyphenol biomarkers with the risk of chronic diseases, a set of statistical inferences are being made simultaneously. This results in a problem well known by the epidemiologists as multiple comparison testing. Several statistical techniques have been developed to counter this problem. The Bonferroni test is considered the simplest and most conservative method to control the family-wise error rate. The false discovery rate is also commonly used, because it is less stringent than family error rate procedures. Despite these statistical techniques, it is highly recommended to retest the hypotheses in another independent study and verify that the results are not a result of chance ([@bib123]). Another approach is to limit the redundancy of variables corresponding to highly correlated polyphenols that cooccur in a same food source. Principal components analysis can then be used to reduce the number of polyphenol variables in the data set to a smaller number of uncorrelated factors ([@bib124]).

MEASUREMENT OF POLYPHENOL EXPOSURE IN OBSERVATIONAL EPIDEMIOLOGIC STUDIES ON CANCER
===================================================================================

Polyphenol exposure has been assessed in numerous observational epidemiologic studies by using either food-composition tables or biomarkers to evaluate the possible role of polyphenols in the prevention of chronic diseases. Because of limitations in the analytic instrumentation and databases used to estimate polyphenol exposure, most research conducted so far has been focused on a limited number of polyphenol variables. These specific approaches largely failed to consider the polyphenol family in all of its complexity. Cancer epidemiologic studies are reviewed here to critically evaluate the utilization of these tools and to make recommendations for future studies.

Polyphenol intake assessment in observational epidemiologic studies on cancer
-----------------------------------------------------------------------------

Most observational studies on polyphenols and cancer risk have reported polyphenol intake based on polyphenol food-composition tables and dietary questionnaires (Supplemental Table 1 under "Supplemental data" in the online issue). Polyphenol food-composition tables were first developed for phytoestrogens (mostly isoflavones and lignans) because of their putative effects on hormone-dependent cancers. Meta-analyses could be conducted only on dietary intake of isoflavones and lignans and the risk of breast ([@bib125], [@bib126]) or prostate ([@bib127]) cancer because of the lack of sufficient data from individual epidemiologic studies on other polyphenols and other cancer sites, except for flavonoid intake and the risk of lung ([@bib10]) and breast ([@bib128]) cancer. These observational epidemiologic studies on phytoestrogens were extended to other specific classes of flavonoids, particularly flavonols ([@bib129]) and flavanols ([@bib130]), after additional food-composition data became available, and later to all main classes of flavonoids ([@bib8], [@bib9]) after the release of the first flavonoid database from the USDA. Because of the relatively recent publication of Phenol-Explorer, the most detailed database on polyphenol contents of foods, this database was still little used to investigate the link between polyphenol intake and risk of cancers ([@bib131]--[@bib134]).

In most observational epidemiologic studies published to date, polyphenols were considered grouped into classes rather than as individual compounds because of the large complexity of the various classes of polyphenols. This reduces the number of variables considered in association studies, but it also presents 2 major drawbacks. First, differences in bioactivities of individual polyphenols within each particular class are masked. Second, it makes it difficult to compare studies in which polyphenol classes rather than individual polyphenols are considered, because no data on the detailed composition of the classes are usually given. For example, a very low intake of total anthocyanidins was measured in the Iowa Women\'s Health Study (0.1 mg/d) ([@bib135]). This value is surprisingly low in comparison to intakes observed in French, Finnish, or Spanish cohorts (35, 47, and 19 mg/d, respectively) ([@bib21], [@bib22], [@bib136]) and raises questions about the reliability of the polyphenol intake measurements in this study and the plausibility of the inverse association found between anthocyanidin intake and cardiovascular disease mortality. Therefore, for future epidemiologic studies, the publication of polyphenol food-composition tables or the study of individual polyphenols rather than total polyphenols in different polyphenol classes is recommended to facilitate comparisons of results obtained in different study populations.

Polyphenol biomarkers in observational epidemiologic studies on cancer
----------------------------------------------------------------------

Cancer-risk associations have also been assessed in observational studies with the use of polyphenol biomarkers ([Table 1](#tbl1){ref-type="table"}), although less frequently than those studies based on intake measurements (Supplemental Table 1 under "Supplemental data" in the online issue). Similar to dietary studies, most polyphenol biomarker research has focused on phytoestrogens and their possible protection against sex hormone--related cancers. Few biomarker studies have been carried out on other classes of polyphenols, such as flavanols and flavanones.

The biomarker-based approach presents the advantage of taking into account interindividual variations in bioavailability and interactions with other dietary compounds ([@bib45]). However, the limited number of biomarker-based observational studies conducted so far limits comparison with studies based on intake measurements. Both types of studies suggest protective effects of isoflavones against breast cancer in Asian populations. In contrast, among men, no associations between isoflavones and the risk of prostate cancer could be observed in studies that used biomarkers ([@bib60], [@bib64]), whereas a meta-analysis on isoflavone intake and prostate cancer in Asian populations showed a reduced risk of cancer in individuals with a high dietary intake of soy isoflavones ([@bib127]). The limited number of biomarker-based studies in diverse populations with very different lifestyles or an insufficient reliability of isoflavone biomarkers over time may explain these discrepancies between results obtained by the 2 different approaches.

Similarly, lignan exposure has been inconsistently associated with postmenopausal breast cancer risk, both in studies based on lignan intake assessment ([@bib125], [@bib132]) and in studies based on lignan biomarkers ([@bib125], [@bib137]). The limited knowledge of the dietary precursors of mammalian lignans ([@bib114]) makes the comparison between both types of studies difficult and suggests that current food-composition tables for the few lignans often present in trace amounts in foods are insufficient to assess exposure to mammalian lignans. Further study of lignins and other potential precursors of mammalian lignans is warranted.

These 2 examples, isoflavones and lignans, show the inconsistencies of observational studies that are based on either biomarkers or intake measurements and the possible bias and systematic errors in the estimation of polyphenol exposures. It will be essential for future work on polyphenol epidemiology to validate polyphenol intake measurements with biomarkers and to better assess the reliability of polyphenol biomarkers. Most biomarker-based studies used a single measurement of polyphenol exposure, and repeated measures might be needed to increase the reliability of long-term exposure measurements.

The use of a larger variety of biomarkers will also be essential in future epidemiologic research. More than 300 polyphenol metabolites have been described in various clinical and experimental studies ([@bib103]), of which any one could represent a potential polyphenol biomarker to be used in some metabolome-wide association studies. The recent and rapid development of metabolomics brings new opportunities to discover novel polyphenol biomarkers and to develop studies on the polyphenol metabolome in which a large number of polyphenol biomarkers could be simultaneously measured ([@bib18], [@bib138]--[@bib140]). Such studies would offer great promise in identifying the phenolic compounds most significant for health. They will also be needed to further validate polyphenol food-composition tables and polyphenol intake measurements in dietary intervention and observational studies.

CONCLUSIONS
===========

Most studies investigating the links between polyphenol exposure and risk of chronic diseases have relied on the estimation of polyphenol intake from dietary questionnaires. The USDA flavonoid databases, and more recently the Phenol-Explorer database, have provided new opportunities to establish links between diseases and intakes of various polyphenols. A limitation of the studies published so far is that they most often measured consumption of total polyphenols or total polyphenols in each class, instead of individual polyphenols, masking their large diversity in terms of structure, physicochemical properties, and biological effects. More studies on individual polyphenols should be conducted in the future. The polyphenol databases now available should allow us to estimate the wide variety of compounds consumed within the diet and help in identifying the components of the polyphenol metabolome that play a major role in the maintenance of health.

Biomarkers are a promising alternative to traditional dietary assessment methods and may reduce biases associated with self-reporting. They may also better reflect exposure of target tissues to polyphenols than intake measurements, which do not take into account interindividual variations in bioavailability. Their application to polyphenol epidemiology has so far been essentially limited to phytoestrogens. The main barrier to the successful use of biomarkers as dietary assessors is the lack of comprehensive and validated analytic methods for their measurement in population studies. These methods should be highly sensitive and specific to be compatible with the low concentrations commonly found in plasma and urine samples. The reliability of these biomarkers over time should also be carefully assessed to ensure that they reflect habitual exposure, particularly for polyphenols and their food sources, which may not be regularly consumed.

There is greater interest than ever in improving and refining the estimation of intake of and exposure to the many nutrients and bioactive compounds regularly consumed within the diet. The development of databases for other food bioactive components and of analytic techniques for their measurement in human biospecimens should greatly contribute to clarify their effects on health and diseases. Progress recently made on the highly complex polyphenol family, and more particularly the development of comprehensive databases on polyphenol content in foods and their metabolism, could be extended to other classes of food bioactive constituents, such as terpenoids, alkaloids, glucosinolates, or fatty acids, to develop a broad information system on dietary constituents, their chemical structures, occurrence and concentrations in foods, biological properties, and effects on health ([@bib29]). This should contribute to the development of metabolome-wide association studies and to the further integration of nutrition and food science into the "omics" era. This is a major challenge for nutritionists of the 21st century, which, if properly addressed, may radically change our understanding of the relations between diet and health.
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======================
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